← 返回

变革肿瘤治疗:个体化免疫治疗的兴起

英文原题:Revolutionizing cancer treatment: the rise of personalized immunotherapies.

查看英文原题

Revolutionizing cancer treatment: the rise of personalized immunotherapies.

PubMed 2024/12/18(内容时间) Discov Oncol Q3 · IF 2.8(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

由于生物疗法可精准靶向癌细胞、减少对周围健康组织的影响,近年来其用于癌症治疗受到越来越多关注。本综述讨论多种生物疗法,重点介绍相较单独传统化疗的先进替代方案。文章探讨DNA和RNA疫苗、T细胞改造、过继细胞转移、CAR-T 细胞疗法、血管生成抑制剂,以及免疫治疗联合化疗,全面展示这些方法的癌症治疗潜力。此外,综述讨论纳米技术提高靶向癌症药物疗效的作用,以及细胞因子和免疫偶联物增强免疫系统对抗肿瘤细胞效力的疗法。文章还讨论基因疗法精准靶向癌症相关基因的潜力,以及溶瘤病毒治疗病毒相关癌症的应用。综述指出,生物方法靶向治疗癌症已取得重大进展,同时也承认药物耐药及部分疗法需要高度特异性等挑战,并突显癌症疫苗、改造T细胞和溶瘤病毒的疗效。生物疗法是癌症治疗有前景的前沿领域,有望带来更个体化、更有效的治疗策略。尽管仍有挑战,持续研究和临床试验对于克服当前局限、提高癌症照护中生物疗法的疗效至关重要。

展开英文摘要原文

Interest in biological therapy for cancer has surged due to its precise targeting of cancer cells and minimized impact on surrounding healthy tissues. This review discusses various biological cancer therapies, highlighting advanced alternatives over conventional chemotherapy alone. It explores DNA and RNA-based vaccines, T-cell modifications, adoptive cell transfer, CAR T cell therapy, angiogenesis inhibitors, and the combination of immunotherapy with chemotherapy, offering a holistic view of the potential in cancer treatment.

Additionally, it discusses the role of nanotechnology in increasing the efficacy of cancer-targeting drugs, as well as cytokine and immunoconjugate therapies for bolstering immune system effectiveness against neoplastic cells. The potential of gene potential for precise targeting of cancer-linked genes and the application of oncolytic viruses against virus-associated cancers are also discussed. The review identifies significant advancements in the targeted treatment of cancer by biological methods.

It acknowledges the challenges, including drug resistance and the need for high specificity in certain therapies, while also highlighting the effectiveness of cancer vaccines, modified T-cells, and oncolytic viruses. Biological therapies are a promising frontier in cancer treatment, offering the potential for more personalized and effective therapeutic strategies. Despite existing challenges, ongoing research and clinical trials are fundamental for overcoming current limitations and enhancing the efficacy of biological therapies in cancer care.

论文信息

作者
Fayyaz A、Haqqi A、Khan R、Irfan M、Khan K、Reiner Ž、Sharifi-Rad J、Calina D
第一作者单位
Atta-Ur-Rahman School of Applied Biosciences, National University of Sciences and Technology, Islamabad, Pakistan.
通讯作者单位
Department of Clinical Pharmacy, University of Medicine and Pharmacy of Craiova, 200349, Craiova, Romania. calinadaniela@gmail.com.Italy
文献类型
综述
期刊
Discover oncology2024 Dec 18
原文标识
PubMed 39692978 · DOI 10.1007/s12672-024-01638-1